For as many as 200 million people around the world affected by peripheral artery disease (PAD), 1 the evolution of endovascular innovations certainly provides a source of optimism. Within 3 decades, ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

Cerenovus PulseRider Aneurysm Neck Bridging Device T shape, Y shape 2.7–3.5, 3.4–4.5 8.6, 10.6 ...

Merit Medical Systems, Inc. Merit Advance Angiographic Needles 18, 19, 20, 21 (smooth and echo-enhanced) 2.5, 4, 7, 9 Merit Medical Systems, Inc. Merit Advance ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...

CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...

In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...

Data from the STRIDE study suggest that race, not sex, is associated with outcomes in acute limb ischemia (ALI) treated with me ...

Investigators from the LIFE-BTK randomized controlled trial evaluating the use of the Drug-Eluting Resorbable Scaffold (Abbott) ...

DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...

Two-year outcomes from the PROMISE II trial assessed transcatheter arterialization of the deep veins (TADV) using the LimFlow S ...